Equities

Celestial Biolabs Ltd

CELESTIAL:NSI

Celestial Biolabs Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)1.75
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Mar 11 2020.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420192018
ASSETS
Cash And Short Term Investments0.230.500.10
Total Receivables, Net37164214
Total Inventory0.346140
Prepaid expenses------
Other current assets, total5.75056
Total current assets43226310
Property, plant & equipment, net129417424
Goodwill, net0.01----
Intangibles, net--550403
Long term investments--03.01
Note receivable - long term------
Other long term assets----0.00
Total assets1721,1931,140
LIABILITIES
Accounts payable3.545.584.34
Accrued expenses------
Notes payable/short-term debt31--0
Current portion long-term debt/capital leases2.50----
Other current liabilities, total187318
Total current liabilities557823
Total long term debt907894
Total debt1237894
Deferred income tax--14(0.27)
Minority interest(0.03)----
Other liabilities, total0.00----
Total liabilities145171117
SHAREHOLDERS EQUITY
Common stock226226226
Additional paid-in capital----0
Retained earnings (accumulated deficit)--797797
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(198)----
Total equity281,0231,023
Total liabilities & shareholders' equity1721,1931,140
Total common shares outstanding232323
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.